OOIR: Observatory of International Research

Papers

(The H4-Index of United European Gastroenterology Journal is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations	131
Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis	88
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutri	84
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group	76
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis	71
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia	65
Implications of the changing epidemiology of inflammatory bowel disease in a changing world	60
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility	60
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‐analysis	53
Environmental risk factors for inflammatory bowel disease	50
European guideline on indications, performance and clinical impact of ¹³C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC	47
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases	47
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation	46
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice	46
New concepts in the treatment of hepatocellular carcinoma	45
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration	44
The gastrointestinal tract in hunger and satiety signalling	42
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden	42
Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study	39
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study	38
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries	35
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease	34
Current status and limitations of artificial intelligence in colonoscopy	32
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better	31
Gut fermentation syndrome: A systematic review of case reports	31

Time trends in incidence and prevalence of chronic pancreatitis: A 25‐year population‐based nationwide study	29
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education ‐ a population‐based cross‐sectional study of incidence, diagnostic process and complications of eosinophilic oesophagi	27
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study	27